Gpcpd1-GPC metabolic pathway is dysfunctional in aging and its deficiency severely perturbs glucose metabolism
Domagoj Cikes,Michael Leutner,Shane J F Cronin,Maria Novatchkova,Lorenz Pfleger,Radka Klepochová,Benjamin Lair,Marlène Lac,Camille Bergoglio,Nathalie Viguerie,Gerhard Dürnberger,Elisabeth Roitinger,Mihaela Grivej,Eric Rullman,Thomas Gustafsson,Astrid Hagelkruys,Geneviève Tavernier,Virginie Bourlier,Claude Knauf,Michael Krebs,Alexandra Kautzky-Willer,Cedric Moro,Martin Krssak,Michael Orthofer,Josef M Penninger
DOI: https://doi.org/10.1038/s43587-023-00551-6
Abstract:Skeletal muscle plays a central role in the regulation of systemic metabolism during lifespan. With aging, this function is perturbed, initiating multiple chronic diseases. Our knowledge of mechanisms responsible for this decline is limited. Glycerophosphocholine phosphodiesterase 1 (Gpcpd1) is a highly abundant muscle enzyme that hydrolyzes glycerophosphocholine (GPC). The physiological functions of Gpcpd1 remain largely unknown. Here we show, in mice, that the Gpcpd1-GPC metabolic pathway is perturbed in aged muscles. Further, muscle-specific, but not liver- or fat-specific, inactivation of Gpcpd1 resulted in severely impaired glucose metabolism. Western-type diets markedly worsened this condition. Mechanistically, Gpcpd1 muscle deficiency resulted in accumulation of GPC, causing an 'aged-like' transcriptomic signature and impaired insulin signaling in young Gpcpd1-deficient muscles. Finally, we report that the muscle GPC levels are markedly altered in both aged humans and patients with type 2 diabetes, displaying a high positive correlation between GPC levels and chronological age. Our findings reveal that the muscle GPCPD1-GPC metabolic pathway has an important role in the regulation of glucose homeostasis and that it is impaired during aging, which may contribute to glucose intolerance in aging.